Shira Levi-Hagbi

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1.

Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1.

Journal: Frontiers in immunology
Published: September 26, 2024

Genome wide association study and genomic risk prediction of age related macular degeneration in Israel.

Genome wide association study and genomic risk prediction of age related macular degeneration in Israel.

Journal: Scientific reports
Published: December 22, 2023

Genome-wide association study and genomic risk prediction of age-related macular degeneration in Israel.

Genome-wide association study and genomic risk prediction of age-related macular degeneration in Israel.

Journal: medRxiv : the preprint server for health sciences
Published: September 21, 2023

CCR1 mediates Müller cell activation and photoreceptor cell death in macular and retinal degeneration.

CCR1 mediates Müller cell activation and photoreceptor cell death in macular and retinal degeneration.

Journal: eLife
Published: June 19, 2022

Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular Degeneration.

Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular Degeneration.

Journal: Investigative ophthalmology & visual science
Published: August 18, 2021

Anti-tumor necrosis factor alpha reduces the proangiogenic effects of activated macrophages derived from patients with age-related macular degeneration.

Anti-tumor necrosis factor alpha reduces the proangiogenic effects of activated macrophages derived from patients with age-related macular degeneration.

Journal: Molecular vision
Published: October 20, 2020

Association of a Variant in VWA3A with Response to Anti-Vascular Endothelial Growth Factor Treatment in Neovascular AMD.

Association of a Variant in VWA3A with Response to Anti-Vascular Endothelial Growth Factor Treatment in Neovascular AMD.

Journal: Investigative ophthalmology & visual science
Published: February 28, 2020

Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment.

Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment.

Journal: Journal of immunology research
Published: January 07, 2019

Evaluation of antioxidant treatments for the modulation of macrophage function in the context of retinal degeneration.

Evaluation of antioxidant treatments for the modulation of macrophage function in the context of retinal degeneration.

Journal: Molecular vision
Published: August 20, 2018

Characterizing the effect of supplements on the phenotype of cultured macrophages from patients with age-related macular degeneration.

Characterizing the effect of supplements on the phenotype of cultured macrophages from patients with age-related macular degeneration.

Journal: Molecular vision
Published: February 15, 2017

Proangiogenic characteristics of activated macrophages from patients with age-related macular degeneration.

Proangiogenic characteristics of activated macrophages from patients with age-related macular degeneration.

Journal: Neurobiology of aging
Published: August 31, 2016

Characterising the phenotype and progression of sporadic adult-onset foveomacular vitelliform dystrophy.

Characterising the phenotype and progression of sporadic adult-onset foveomacular vitelliform dystrophy.

Journal: The British journal of ophthalmology
Published: August 11, 2015
Showing 1-12 of 18

Last Updated: 09/26/2026